Clinical Trial Update: Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy

View source ↗

Summary

A clinical trial update describes the development of a remote monitoring model for patients with HR-positive, HER2-negative breast cancer treated with CDK4/6 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Breast Cancer, CDK4/6 Inhibitor | Status: NOT_YET_RECRUITING